Experience with the Avalon® bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO
Objective: We report a single centre experience of neonatal respiratory ECMO using the Avalon® double-lumen venous cannula and compare it with reports in the literature. Results: Between 2008 and 2012, the Avalon® cannula was used in 72 neonates: median age at cannulation was 1.8 days (IQR 1.2-2.8 d...
Gespeichert in:
| Veröffentlicht in: | Perfusion 2015-04, Vol.30 (3), p.250-254 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 254 |
|---|---|
| container_issue | 3 |
| container_start_page | 250 |
| container_title | Perfusion |
| container_volume | 30 |
| creator | Speggiorin, S Robinson, SG Harvey, C Westrope, C Faulkner, GM Kirkland, P Peek, GJ |
| description | Objective:
We report a single centre experience of neonatal respiratory ECMO using the Avalon® double-lumen venous cannula and compare it with reports in the literature.
Results:
Between 2008 and 2012, the Avalon® cannula was used in 72 neonates: median age at cannulation was 1.8 days (IQR 1.2-2.8 days) and bodyweight 3.4 Kg (3.0–3.7 Kg). Meconium aspiration syndrome (61.1%), persistent hypertension of the newborn (25%) and congenital diaphragmatic hernia (5.6%) were the most common diagnoses. Complications occurred in 19 patients (26.4%): cannula site bleeding in 6 (8.3%), the cannula perforating the right atrial wall and requiring emergency midline sternotomy in 5 (6.9%) and the cannula needing repositioning in 3 (4.2%).
Overall survival at discharge or transfer to the referring hospital was 88.8%. Successful wean off ECMO occurred in 68 patients (94.4%) after a median of 90.5 hours (63.4 – 136.11). ECMO support was withdrawn in 4 patients (5.6%).
Conclusions:
The Avalon® dual-lumen veno-venous cannula can be used for respiratory ECMO in the neonatal population. However, as the incidence of right atrial perforation is not negligible, we suspended its used in this group of patients. |
| doi_str_mv | 10.1177/0267659114540020 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1664776914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0267659114540020</sage_id><sourcerecordid>1664776914</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-953c958ed1d65df72eec6d90b48503397273e03ddc487aaf0ef31793ec58f96e3</originalsourceid><addsrcrecordid>eNp1kU1LAzEQhoMoWj_uniTgxctqsvnaHEupH6D0ouBtSbOzdmWb1GS36p_yR_jLTKmKFLzMDMwz77zMIHRMyTmlSl2QXCopNKVccEJysoUGlCuVUUoft9Fg1c5W_T20H-MzIYRzznbRXs61yguaD5Advy0gNOAs4Nemm-FuBni4NK13nx942liTalz5ftpC1vZzcHgJzmer0EdsjXN9a3DtA3bgnekSHSAummA6H97xeHQ3OUQ7tWkjHH3nA_RwOb4fXWe3k6ub0fA2s0yKLtOCWS0KqGglRVWrHMDKSpMpLwRhLDlWDAirKssLZUxNoGZUaQZWFLWWwA7Q2Vp3EfxLD7Er50200LYmWetjSaVMx5Ga8oSebqDPvg8uuUuUYoXQjMpEkTVlg48xQF0uQjM34b2kpFw9oNx8QBo5-Rbup3Oofgd-Lp6AbA1E8wR_tv4n-AUwk42y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1673859316</pqid></control><display><type>article</type><title>Experience with the Avalon® bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO</title><source>SAGE Complete A-Z List</source><source>MEDLINE</source><creator>Speggiorin, S ; Robinson, SG ; Harvey, C ; Westrope, C ; Faulkner, GM ; Kirkland, P ; Peek, GJ</creator><creatorcontrib>Speggiorin, S ; Robinson, SG ; Harvey, C ; Westrope, C ; Faulkner, GM ; Kirkland, P ; Peek, GJ</creatorcontrib><description>Objective:
We report a single centre experience of neonatal respiratory ECMO using the Avalon® double-lumen venous cannula and compare it with reports in the literature.
Results:
Between 2008 and 2012, the Avalon® cannula was used in 72 neonates: median age at cannulation was 1.8 days (IQR 1.2-2.8 days) and bodyweight 3.4 Kg (3.0–3.7 Kg). Meconium aspiration syndrome (61.1%), persistent hypertension of the newborn (25%) and congenital diaphragmatic hernia (5.6%) were the most common diagnoses. Complications occurred in 19 patients (26.4%): cannula site bleeding in 6 (8.3%), the cannula perforating the right atrial wall and requiring emergency midline sternotomy in 5 (6.9%) and the cannula needing repositioning in 3 (4.2%).
Overall survival at discharge or transfer to the referring hospital was 88.8%. Successful wean off ECMO occurred in 68 patients (94.4%) after a median of 90.5 hours (63.4 – 136.11). ECMO support was withdrawn in 4 patients (5.6%).
Conclusions:
The Avalon® dual-lumen veno-venous cannula can be used for respiratory ECMO in the neonatal population. However, as the incidence of right atrial perforation is not negligible, we suspended its used in this group of patients.</description><identifier>ISSN: 0267-6591</identifier><identifier>EISSN: 1477-111X</identifier><identifier>DOI: 10.1177/0267659114540020</identifier><identifier>PMID: 24972812</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Disease-Free Survival ; Extracorporeal Membrane Oxygenation - adverse effects ; Extracorporeal Membrane Oxygenation - instrumentation ; Extracorporeal Membrane Oxygenation - methods ; Female ; Humans ; Infant, Newborn ; Male ; Meconium Aspiration Syndrome - mortality ; Meconium Aspiration Syndrome - therapy ; Persistent Fetal Circulation Syndrome - mortality ; Persistent Fetal Circulation Syndrome - therapy ; Retrospective Studies ; Survival Rate ; Vascular Access Devices</subject><ispartof>Perfusion, 2015-04, Vol.30 (3), p.250-254</ispartof><rights>The Author(s) 2014</rights><rights>The Author(s) 2014.</rights><rights>SAGE Publications © Apr 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-953c958ed1d65df72eec6d90b48503397273e03ddc487aaf0ef31793ec58f96e3</citedby><cites>FETCH-LOGICAL-c365t-953c958ed1d65df72eec6d90b48503397273e03ddc487aaf0ef31793ec58f96e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0267659114540020$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0267659114540020$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24972812$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Speggiorin, S</creatorcontrib><creatorcontrib>Robinson, SG</creatorcontrib><creatorcontrib>Harvey, C</creatorcontrib><creatorcontrib>Westrope, C</creatorcontrib><creatorcontrib>Faulkner, GM</creatorcontrib><creatorcontrib>Kirkland, P</creatorcontrib><creatorcontrib>Peek, GJ</creatorcontrib><title>Experience with the Avalon® bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO</title><title>Perfusion</title><addtitle>Perfusion</addtitle><description>Objective:
We report a single centre experience of neonatal respiratory ECMO using the Avalon® double-lumen venous cannula and compare it with reports in the literature.
Results:
Between 2008 and 2012, the Avalon® cannula was used in 72 neonates: median age at cannulation was 1.8 days (IQR 1.2-2.8 days) and bodyweight 3.4 Kg (3.0–3.7 Kg). Meconium aspiration syndrome (61.1%), persistent hypertension of the newborn (25%) and congenital diaphragmatic hernia (5.6%) were the most common diagnoses. Complications occurred in 19 patients (26.4%): cannula site bleeding in 6 (8.3%), the cannula perforating the right atrial wall and requiring emergency midline sternotomy in 5 (6.9%) and the cannula needing repositioning in 3 (4.2%).
Overall survival at discharge or transfer to the referring hospital was 88.8%. Successful wean off ECMO occurred in 68 patients (94.4%) after a median of 90.5 hours (63.4 – 136.11). ECMO support was withdrawn in 4 patients (5.6%).
Conclusions:
The Avalon® dual-lumen veno-venous cannula can be used for respiratory ECMO in the neonatal population. However, as the incidence of right atrial perforation is not negligible, we suspended its used in this group of patients.</description><subject>Disease-Free Survival</subject><subject>Extracorporeal Membrane Oxygenation - adverse effects</subject><subject>Extracorporeal Membrane Oxygenation - instrumentation</subject><subject>Extracorporeal Membrane Oxygenation - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Male</subject><subject>Meconium Aspiration Syndrome - mortality</subject><subject>Meconium Aspiration Syndrome - therapy</subject><subject>Persistent Fetal Circulation Syndrome - mortality</subject><subject>Persistent Fetal Circulation Syndrome - therapy</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><subject>Vascular Access Devices</subject><issn>0267-6591</issn><issn>1477-111X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU1LAzEQhoMoWj_uniTgxctqsvnaHEupH6D0ouBtSbOzdmWb1GS36p_yR_jLTKmKFLzMDMwz77zMIHRMyTmlSl2QXCopNKVccEJysoUGlCuVUUoft9Fg1c5W_T20H-MzIYRzznbRXs61yguaD5Advy0gNOAs4Nemm-FuBni4NK13nx942liTalz5ftpC1vZzcHgJzmer0EdsjXN9a3DtA3bgnekSHSAummA6H97xeHQ3OUQ7tWkjHH3nA_RwOb4fXWe3k6ub0fA2s0yKLtOCWS0KqGglRVWrHMDKSpMpLwRhLDlWDAirKssLZUxNoGZUaQZWFLWWwA7Q2Vp3EfxLD7Er50200LYmWetjSaVMx5Ga8oSebqDPvg8uuUuUYoXQjMpEkTVlg48xQF0uQjM34b2kpFw9oNx8QBo5-Rbup3Oofgd-Lp6AbA1E8wR_tv4n-AUwk42y</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Speggiorin, S</creator><creator>Robinson, SG</creator><creator>Harvey, C</creator><creator>Westrope, C</creator><creator>Faulkner, GM</creator><creator>Kirkland, P</creator><creator>Peek, GJ</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Experience with the Avalon® bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO</title><author>Speggiorin, S ; Robinson, SG ; Harvey, C ; Westrope, C ; Faulkner, GM ; Kirkland, P ; Peek, GJ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-953c958ed1d65df72eec6d90b48503397273e03ddc487aaf0ef31793ec58f96e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Disease-Free Survival</topic><topic>Extracorporeal Membrane Oxygenation - adverse effects</topic><topic>Extracorporeal Membrane Oxygenation - instrumentation</topic><topic>Extracorporeal Membrane Oxygenation - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Male</topic><topic>Meconium Aspiration Syndrome - mortality</topic><topic>Meconium Aspiration Syndrome - therapy</topic><topic>Persistent Fetal Circulation Syndrome - mortality</topic><topic>Persistent Fetal Circulation Syndrome - therapy</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><topic>Vascular Access Devices</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Speggiorin, S</creatorcontrib><creatorcontrib>Robinson, SG</creatorcontrib><creatorcontrib>Harvey, C</creatorcontrib><creatorcontrib>Westrope, C</creatorcontrib><creatorcontrib>Faulkner, GM</creatorcontrib><creatorcontrib>Kirkland, P</creatorcontrib><creatorcontrib>Peek, GJ</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Perfusion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Speggiorin, S</au><au>Robinson, SG</au><au>Harvey, C</au><au>Westrope, C</au><au>Faulkner, GM</au><au>Kirkland, P</au><au>Peek, GJ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experience with the Avalon® bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO</atitle><jtitle>Perfusion</jtitle><addtitle>Perfusion</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>30</volume><issue>3</issue><spage>250</spage><epage>254</epage><pages>250-254</pages><issn>0267-6591</issn><eissn>1477-111X</eissn><abstract>Objective:
We report a single centre experience of neonatal respiratory ECMO using the Avalon® double-lumen venous cannula and compare it with reports in the literature.
Results:
Between 2008 and 2012, the Avalon® cannula was used in 72 neonates: median age at cannulation was 1.8 days (IQR 1.2-2.8 days) and bodyweight 3.4 Kg (3.0–3.7 Kg). Meconium aspiration syndrome (61.1%), persistent hypertension of the newborn (25%) and congenital diaphragmatic hernia (5.6%) were the most common diagnoses. Complications occurred in 19 patients (26.4%): cannula site bleeding in 6 (8.3%), the cannula perforating the right atrial wall and requiring emergency midline sternotomy in 5 (6.9%) and the cannula needing repositioning in 3 (4.2%).
Overall survival at discharge or transfer to the referring hospital was 88.8%. Successful wean off ECMO occurred in 68 patients (94.4%) after a median of 90.5 hours (63.4 – 136.11). ECMO support was withdrawn in 4 patients (5.6%).
Conclusions:
The Avalon® dual-lumen veno-venous cannula can be used for respiratory ECMO in the neonatal population. However, as the incidence of right atrial perforation is not negligible, we suspended its used in this group of patients.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>24972812</pmid><doi>10.1177/0267659114540020</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0267-6591 |
| ispartof | Perfusion, 2015-04, Vol.30 (3), p.250-254 |
| issn | 0267-6591 1477-111X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1664776914 |
| source | SAGE Complete A-Z List; MEDLINE |
| subjects | Disease-Free Survival Extracorporeal Membrane Oxygenation - adverse effects Extracorporeal Membrane Oxygenation - instrumentation Extracorporeal Membrane Oxygenation - methods Female Humans Infant, Newborn Male Meconium Aspiration Syndrome - mortality Meconium Aspiration Syndrome - therapy Persistent Fetal Circulation Syndrome - mortality Persistent Fetal Circulation Syndrome - therapy Retrospective Studies Survival Rate Vascular Access Devices |
| title | Experience with the Avalon® bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T02%3A05%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experience%20with%20the%20Avalon%C2%AE%20bicaval%20double-lumen%20veno-venous%20cannula%20for%20neonatal%20respiratory%20ECMO&rft.jtitle=Perfusion&rft.au=Speggiorin,%20S&rft.date=2015-04-01&rft.volume=30&rft.issue=3&rft.spage=250&rft.epage=254&rft.pages=250-254&rft.issn=0267-6591&rft.eissn=1477-111X&rft_id=info:doi/10.1177/0267659114540020&rft_dat=%3Cproquest_cross%3E1664776914%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1673859316&rft_id=info:pmid/24972812&rft_sage_id=10.1177_0267659114540020&rfr_iscdi=true |